Free Trial
LON:FDBK

Feedback Interim Earnings Results & Report

Feedback logo
GBX 3.60 +0.02 (+0.56%)
As of 09:59 AM Eastern

Feedback reported Interim earnings on February 25, 2025. The company reported EPS of -GBX 14.22.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

Feedback EPS Results

Actual EPS
-GBX 14.22
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Feedback Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Feedback Interim Earnings FAQ

Feedback (LON:FDBK) reported earnings of -GBX 14.22 per share for Interim. The report was announced on Tuesday, February 25, 2025.

Feedback Earnings Headlines

Feedback (LON:FDBK) Shares Down 19.4% - Should You Sell?
Your Social Security check is scheduled for a 22% cut
The U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.tc pixel
See More Feedback Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Feedback? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Feedback and other key companies, straight to your email.

About Feedback

Feedback (LON:FDBK) (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical. Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients. By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers. Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is a patient-facing platform that gives patients access and control over their diagnostic and other clinical data. The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

View Feedback Profile